| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.42 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |